Proteinlogic Limited

Technical and Commercial Feasibility of a blood test for prediction of response to interferon treatment in Chronic Hepatitis B patients

Feasibility Studies

Research to create point-of-care TB diagnostic prototype from ProteinLogic unique TB biomarker signature and Microtest novel rapid diagnostic platform [MicroLogic].

Collaborative R&D

Feasibility of rapid point-of-care diagnostic test for TB

Feasibility Studies

Feasibility of developing a novel biomarker signature as an innovative diagnostic for tuberculosis (TB)

Feasibility Studies

Assessment of the market opportunity and unmet need for a hepatitis B diagnostic test which is predictive of response to treatment

Special Interest Group